NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.40
-0.20 (-2.63%)
At close: Oct 23, 2026, 4:00 PM EDT
7.40
0.00 (0.00%)
After-hours: Oct 23, 2026, 4:10 PM EDT
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $92.93 million as of October 23, 2026. It is the 25,429th most valuable company in the world and the 4,125th biggest in the United States. Its market cap has increased by 148.35% in one year.
Market Cap
92.93M
Enterprise Value
84.88M
1-Year Change
148.35%
Global Rank
Country Rank
#4,125 United States
Category
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $92.93M, an increase of 405.81%. That is a compound annual growth rate of 65.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 92.93M | 92.14% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 103.45M |
| PolyPid | 102.98M |
| Milestone Pharmaceuticals | 99.72M |
| Coya Therapeutics | 98.29M |
| Aardvark Therapeutics | 96.29M |
| Tenax Therapeutics | 95.95M |
| Tonix Pharmaceuticals Holding | 95.36M |
| Atara Biotherapeutics | 94.96M |